JPS6345223A - ひと免疫不全ウイルス性疾患処置剤 - Google Patents

ひと免疫不全ウイルス性疾患処置剤

Info

Publication number
JPS6345223A
JPS6345223A JP1557487A JP1557487A JPS6345223A JP S6345223 A JPS6345223 A JP S6345223A JP 1557487 A JP1557487 A JP 1557487A JP 1557487 A JP1557487 A JP 1557487A JP S6345223 A JPS6345223 A JP S6345223A
Authority
JP
Japan
Prior art keywords
sulfate
polysaccharide
agent according
therapeutic agent
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1557487A
Other languages
English (en)
Japanese (ja)
Other versions
JPH027577B2 (esLanguage
Inventor
Ryuzo Ueno
隆三 上野
Takashi Ueno
隆司 上野
Yuko Kuno
祐子 久能
Akihiko Tabata
昭彦 田畑
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ueno Seiyaku Oyo Kenkyujo KK
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Publication of JPS6345223A publication Critical patent/JPS6345223A/ja
Publication of JPH027577B2 publication Critical patent/JPH027577B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP1557487A 1986-04-04 1987-01-26 ひと免疫不全ウイルス性疾患処置剤 Granted JPS6345223A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP61-78470 1986-04-04
JP7847086 1986-04-04
JP61-78471 1986-04-04
JP61-93019 1986-04-21

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP23336388A Division JPH01151521A (ja) 1986-04-04 1988-09-16 レトロウイルス性疾患処置剤

Publications (2)

Publication Number Publication Date
JPS6345223A true JPS6345223A (ja) 1988-02-26
JPH027577B2 JPH027577B2 (esLanguage) 1990-02-19

Family

ID=13662901

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1557487A Granted JPS6345223A (ja) 1986-04-04 1987-01-26 ひと免疫不全ウイルス性疾患処置剤

Country Status (3)

Country Link
JP (1) JPS6345223A (esLanguage)
ZA (1) ZA872359B (esLanguage)
ZM (1) ZM3087A1 (esLanguage)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01103601A (ja) * 1987-07-07 1989-04-20 Ajinomoto Co Inc 新規な抗ウィルス剤
JPH01132526A (ja) * 1987-10-15 1989-05-25 Luitpold Werk Chem Pharmz Fab 薬剤組成物
JPH02145601A (ja) * 1988-11-28 1990-06-05 Ajinomoto Co Inc カードランまたはレンチナンの硫酸エステルまたはその塩の製造方法
WO1990009181A1 (en) * 1989-02-10 1990-08-23 Taiho Pharmaceutical Co., Ltd. Anti-hiv drug
WO1992002231A1 (en) * 1990-08-02 1992-02-20 Taiho Pharmaceutical Co., Ltd. Anti-human immunodeficiency virus agent
EP0531016A2 (en) 1991-08-29 1993-03-10 Tanabe Seiyaku Co., Ltd. Polysulfate of beta-cyclodextrin derivative and process for preparing the same
US5248675A (en) * 1990-03-15 1993-09-28 Tanabe Seiyaku Co., Ltd. Polysulfate of cyclodextrin derivative and process for preparing the same
US5250520A (en) * 1990-03-15 1993-10-05 Tanabe Seiyaku Co., Ltd. Polysulfate of cyclodextrin derivative and process for preparing the same
US5639738A (en) * 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5811410A (en) * 1989-09-21 1998-09-22 Hyal Pharmaceutical Corporation Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID
US5817644A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
US5942498A (en) * 1992-02-20 1999-08-24 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5990095A (en) * 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US6022866A (en) * 1991-07-03 2000-02-08 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US6337390B1 (en) 1996-05-16 2002-01-08 Nissan Food Products Co., Ltd. Compounds comprising sulfated nonulonic acid having antiviral activity
WO2005094851A1 (ja) * 2004-03-31 2005-10-13 National Institute Of Advanced Industrial Science And Technology 動物臓器から抽出した水溶性画分、その製造方法、逆転写反応阻害剤、逆転写酵素阻害剤、ウイルス増殖阻害剤及び医薬組成物
JP2015117198A (ja) * 2013-12-18 2015-06-25 日本薬品株式会社 コンドロイチン硫酸オリゴ糖を含む免疫賦活剤及びその製造方法
JP2016164179A (ja) * 2016-04-11 2016-09-08 日本薬品株式会社 コンドロイチン硫酸オリゴ糖を含む免疫賦活剤及びその製造方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5141083A (ja) * 1974-10-04 1976-04-06 Shigeo Suzuki Kodonoseibutsukatsuseiojusurudekisutoranhoririnsanesuteru no seizoho
JPS58918A (ja) * 1981-05-15 1983-01-06 ライカ−・ラボラトリ−ス・インコ−ポレ−テツド 抗疱疹ウイルス剤
JPS62215529A (ja) * 1986-01-16 1987-09-22 マツクス−プランク−ゲゼルシヤフト・ツア・フエルデルンク・デア・ヴイツセンシヤフテン・エ−・フアウ 逆転写酵素阻害剤を含む医薬組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5141083A (ja) * 1974-10-04 1976-04-06 Shigeo Suzuki Kodonoseibutsukatsuseiojusurudekisutoranhoririnsanesuteru no seizoho
JPS58918A (ja) * 1981-05-15 1983-01-06 ライカ−・ラボラトリ−ス・インコ−ポレ−テツド 抗疱疹ウイルス剤
JPS62215529A (ja) * 1986-01-16 1987-09-22 マツクス−プランク−ゲゼルシヤフト・ツア・フエルデルンク・デア・ヴイツセンシヤフテン・エ−・フアウ 逆転写酵素阻害剤を含む医薬組成物

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01103601A (ja) * 1987-07-07 1989-04-20 Ajinomoto Co Inc 新規な抗ウィルス剤
JPH01132526A (ja) * 1987-10-15 1989-05-25 Luitpold Werk Chem Pharmz Fab 薬剤組成物
JPH02145601A (ja) * 1988-11-28 1990-06-05 Ajinomoto Co Inc カードランまたはレンチナンの硫酸エステルまたはその塩の製造方法
WO1990009181A1 (en) * 1989-02-10 1990-08-23 Taiho Pharmaceutical Co., Ltd. Anti-hiv drug
US5811410A (en) * 1989-09-21 1998-09-22 Hyal Pharmaceutical Corporation Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID
US5929048A (en) * 1989-09-21 1999-07-27 Hyal Pharmaceutical Corporation Treatment of conditions and disease
US6194392B1 (en) 1989-09-21 2001-02-27 Hyal Pharmaceutical Corporation Treatment of conditions and disease
US5985851A (en) * 1989-09-21 1999-11-16 Hyal Pharmaceutical Corporation Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
US5985850A (en) * 1989-09-21 1999-11-16 Hyal Pharmaceuticals Corporation Compositions comprising hyaluronic acid and drugs
US5932560A (en) * 1989-09-21 1999-08-03 Hyal Pharmaceutical Corporation Treatment of conditions and disease
US5830882A (en) * 1989-09-21 1998-11-03 Hyal Pharmaceutical Corporation Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
US5914314A (en) * 1989-09-21 1999-06-22 Hyal Pharmaceutical Corporation Use of a form of hyaluronic acid and a medicinal agent for reducing rejection of organs transplantation in mammals
US6069135A (en) * 1989-09-21 2000-05-30 Hyal Pharmaceutical Corporation Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents
US5248675A (en) * 1990-03-15 1993-09-28 Tanabe Seiyaku Co., Ltd. Polysulfate of cyclodextrin derivative and process for preparing the same
US5250520A (en) * 1990-03-15 1993-10-05 Tanabe Seiyaku Co., Ltd. Polysulfate of cyclodextrin derivative and process for preparing the same
WO1992002231A1 (en) * 1990-08-02 1992-02-20 Taiho Pharmaceutical Co., Ltd. Anti-human immunodeficiency virus agent
US5817644A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
US6022866A (en) * 1991-07-03 2000-02-08 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5990095A (en) * 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5385891A (en) * 1991-08-29 1995-01-31 Tanabe Seiyaku Co., Ltd. Polysulfate of β-cyclodextrin derivative and process for preparing the same
EP0531016A2 (en) 1991-08-29 1993-03-10 Tanabe Seiyaku Co., Ltd. Polysulfate of beta-cyclodextrin derivative and process for preparing the same
US5942498A (en) * 1992-02-20 1999-08-24 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5914322A (en) * 1992-02-20 1999-06-22 Hyal Pharmaceutical Corporation Treatment of disease and conditions
US5639738A (en) * 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US6147059A (en) * 1992-02-20 2000-11-14 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6337390B1 (en) 1996-05-16 2002-01-08 Nissan Food Products Co., Ltd. Compounds comprising sulfated nonulonic acid having antiviral activity
US6541461B2 (en) 1996-05-16 2003-04-01 Nissin Food Products Co., Ltd. Compounds having antiviral activity
US6835720B2 (en) 1996-05-16 2004-12-28 Nissin Food Products Co., Ltd. Compounds having antiviral activity
WO2005094851A1 (ja) * 2004-03-31 2005-10-13 National Institute Of Advanced Industrial Science And Technology 動物臓器から抽出した水溶性画分、その製造方法、逆転写反応阻害剤、逆転写酵素阻害剤、ウイルス増殖阻害剤及び医薬組成物
JP2005314386A (ja) * 2004-03-31 2005-11-10 National Institute Of Advanced Industrial & Technology 動物臓器から抽出した水溶性画分、その製造方法、逆転写反応阻害剤、逆転写酵素阻害剤、ウイルス増殖阻害剤及び医薬組成物
JP2015117198A (ja) * 2013-12-18 2015-06-25 日本薬品株式会社 コンドロイチン硫酸オリゴ糖を含む免疫賦活剤及びその製造方法
JP2016164179A (ja) * 2016-04-11 2016-09-08 日本薬品株式会社 コンドロイチン硫酸オリゴ糖を含む免疫賦活剤及びその製造方法

Also Published As

Publication number Publication date
ZA872359B (en) 1988-04-27
JPH027577B2 (esLanguage) 1990-02-19
ZM3087A1 (en) 1989-07-28

Similar Documents

Publication Publication Date Title
JPS6345223A (ja) ひと免疫不全ウイルス性疾患処置剤
EP0240098A2 (en) Oligo and polysaccharides for the treatment of diseases caused by retroviruses
EP0270317A2 (en) Pharmaceutical compositions for the treatment of diseases caused by viruses
Blondin et al. Biological activities of polysaccharides from marine algae
US5322841A (en) Method for producing neutral glucans for pharmaceutical applications
US5908837A (en) Methods of using low molecular weight heparins for prevention or treatment of pathological processes
US5320849A (en) Anti-virus agent
AU705189B2 (en) The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
US3766167A (en) Orally active anticoagulant
JP3523654B2 (ja) 薬用組成物
JPS6117A (ja) ムコ多糖系癌転移抑制剤
JPS62215529A (ja) 逆転写酵素阻害剤を含む医薬組成物
JP2010534672A (ja) 終末糖化産物受容体（ｒａｇｅ）の連結を阻止するための方法
EP0423240B1 (en) Modulation of virus-host cell interactions using cyclic oligosaccharides
EP1937308A1 (en) Synthetic polyvalent carbohydrates as components of microbicides
JPS6152125B2 (esLanguage)
JPH02108624A (ja) 抗ｈｉｖ作用を有するヘパリンフラグメント及びフラクション
NO174834B (no) Fremgangsmåte til fremstilling av farmasöytisk kombinasjonspreparat
Dziarski Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin.
JPH07506572A (ja) Ｃｄ４及びｈ２ヒストンを含有する抗ウイルス剤
JPH08109134A (ja) 細胞変成抑制並びに臓器毒性軽減剤
JPH01132526A (ja) 薬剤組成物
JPH01151521A (ja) レトロウイルス性疾患処置剤
Balazs et al. Interaction of amino sugars and amino sugar-containing macromolecules with viruses, cells, and tissues
JPH01199915A (ja) ウイルス性疾患処置剤